DNL343

· Denali Therapeutics Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for DNL343, covering 2024-06-20 to 2026-01-28. Get the full timeline:

Most recent: Clinical Trial Update: HEALEY ALS Platform Trial - Regimen G DNL343 [Phase 2, Phase 3]